FDA Clears Pfizer Vaccine For Adults Over 50

[admin]

Federal regulators have approved vaccine for adults age 50 and older to prevent pneumococcal disease, including the most common type of pneumonia. Friday’s announcement from the Food and Drug Administration that it has approved Pfizer Inc.’s best-selling Prevnar 13 vaccine for such use was widely anticipated. It comes a little more than a month [...]

More...